Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ORDYU
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
LIN-002
|
|||||
| Synonyms |
AF-Lx-trastuzumab; Auristatin-F-Lx-trastuzumab; trastuzumab-Lx-AF; LIN 002; LIN002
Click to Show/Hide
|
|||||
| Organization |
LinXis B.V.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||